Exelixis Tech Stack
Public oncology company with 30-year track record in cancer drug discovery and commercialization
Exelixis is a publicly traded oncology company operating across drug discovery, clinical development, and commercialization with a 1,000+ person workforce. The tech stack reveals a mature pharma infrastructure: SAS and R for biostatistics, NONMEM for pharmacokinetic modeling, LC-MS/MS for lab analysis, Veeva RIM for regulatory intelligence, and AWS-backed data pipelines (Databricks, Glue, EMR, Lambda, dbt). Hiring is skewed heavily toward research and clinical roles (20 research, 14 healthcare, 12 legal positions) with director-level concentration (58 of 126 open roles), signaling a company scaling specialized expertise rather than engineering capacity.
Tech Stack 58 technologies
What Exelixis Is Building
◆Challenges
- Compliance with global icsr regulations
- Regulatory submissions
- Compliance with global regulatory requirements
- Ensuring reliability and performance
- Managing cros within timelines and budgets
- Launching new drug in mcrc
- Improving contracting systems
- Reducing deviations and capas
- Privacy incident response
- Budget negotiation process
▲Active Projects
- Speaker bureau content development
- Process optimization and sop development
- Clinical pharmacology strategy development
- Key account engagement plans
- Advisory boards
- Early stage clinical trials
- Cdm process improvement initiatives
- Develop automated analysis tools
- Develop edit checks and custom listings
- Promotional tactics for zanza launch
Hiring Activity
Department
Seniority
Notable leadership hires: DMPK Director, Biostatistics Director, Scientific Publications Director, Medical Director, Director, PV Operations
